ARCHIVES

DCT Programs Status Reported to Board

This article is from The Cancer Letter archive.

Vol. 11 No. 27 | July 5, 1985

Download PDF Visit The Full Archive

Related Articles

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

In Brief: NCI May Lose Some Hard-Won New Positions For Ford’s Federal Job Cuts; Ask $9898.5 Million For Fiscal 1976

October 25, 1974

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013